Biotech · Private company
Effector Therapeutics
Track this companyFree. Adds Effector Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- AbemaciclibPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- AvelumabPhase 2 · Microsatellite Stable Relapsed or Refractory Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- eFT226Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- eFT508Phase 2 · Microsatellite Stable Relapsed or Refractory Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- eFT508Phase 2 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- eFT508Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- eFT508Phase 2 · Castrate-resistant Prostate Cancer (CRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- SotorasibPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- TomivosertibPhase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tomivosertib (eFT-508)Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Tomivosertib (eFT-508)Phase 2 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- ZotatifinPhase 1 · Corona Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)PHASE1 · TERMINATED · started Sep 29, 2023ClinicalTrials.gov NCT05744739 · fetched Nov 12, 2026
- Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast CancerPHASE2 · COMPLETED · started Mar 20, 2023ClinicalTrials.gov NCT05101564 · fetched Nov 12, 2026
- Intravenous Zotatifin in Adults With Mild or Moderate COVID-19PHASE1 · COMPLETED · started Jul 1, 2021ClinicalTrials.gov NCT04632381 · fetched Nov 12, 2026
- Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)PHASE2 · UNKNOWN · started Jun 2, 2021ClinicalTrials.gov NCT04622007 · fetched Nov 12, 2026
- Study of eFT226 in Subjects With Selected Advanced Solid Tumor MalignanciesPHASE1_PHASE2 · UNKNOWN · started Oct 25, 2019ClinicalTrials.gov NCT04092673 · fetched Nov 12, 2026
- An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate CancerPHASE2 · TERMINATED · started Nov 27, 2018ClinicalTrials.gov NCT03690141 · fetched Nov 12, 2026
- Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor TherapyPHASE2 · COMPLETED · started Jul 25, 2018ClinicalTrials.gov NCT03616834 · fetched Nov 12, 2026
- A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCCPHASE2 · TERMINATED · started Nov 21, 2017ClinicalTrials.gov NCT03318562 · fetched Nov 12, 2026
- A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal CancerPHASE2 · COMPLETED · started Sep 18, 2017ClinicalTrials.gov NCT03258398 · fetched Nov 12, 2026
- A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological MalignanciesPHASE1_PHASE2 · TERMINATED · started Feb 8, 2017ClinicalTrials.gov NCT02937675 · fetched Nov 12, 2026
- A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Dec 3, 2015ClinicalTrials.gov NCT02605083 · fetched Nov 12, 2026